EXAS a Bullish Outlook
As I predicted before, I had a 100% success rate. Let's consider a long position based on the current technical indicators.
Trend Line: We have a yellow trend line where the price bounced in 2016 and 2022. We are now approaching this trend line again.
Bat Pattern: The bat pattern indicates that point C, which is the 0.886 Fibonacci retracement, aligns exactly with the yellow trend line. The price at point C is $37.87.
Parallel Channel: The parallel channel also converges at the same point.
Given these confluences, the price is expected to bounce from this level. Here is my trading plan:
Stop Loss: $29.00
Entry Level: $37 / $38
First Take Profit: $99.00 (50% of the position)
Final Take Profit: $140.00
Additionally, the RSI has reached the oversold area, further supporting the likelihood of a price bounce from this level.
Disclaimer: I am not a financial advisor.
Trend Line: We have a yellow trend line where the price bounced in 2016 and 2022. We are now approaching this trend line again.
Bat Pattern: The bat pattern indicates that point C, which is the 0.886 Fibonacci retracement, aligns exactly with the yellow trend line. The price at point C is $37.87.
Parallel Channel: The parallel channel also converges at the same point.
Given these confluences, the price is expected to bounce from this level. Here is my trading plan:
Stop Loss: $29.00
Entry Level: $37 / $38
First Take Profit: $99.00 (50% of the position)
Final Take Profit: $140.00
Additionally, the RSI has reached the oversold area, further supporting the likelihood of a price bounce from this level.
Disclaimer: I am not a financial advisor.
Note
Previous prediction:
Note
I have longed for 
EXAS at $42. It seems to have bottomed. My stop loss is set at $36. My first take profit target is at $74, 2TP at $98
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.